Haleon Launches 24 Hour Voltarol Medicated Plaster In The UK

Voltarol One A Day Muscle Pain Relief Medicated Plaster provides up to 24 hours relief from pain and inflammation, according to manufacturer Haleon.

back pain
Treatment Aims To Change Standard Of Care For CLBP patients • Source: Alamy

UK pain sufferers now have an additional option to turn to thanks to an line extension to the Voltarol topical analgesic brand from Haleon.

Containing 140mg diclofenac sodium, Voltarol One A Day Muscle Pain Relief Medicated Plaster provides up to 24 hours of relief from pain and inflammation, according to the firm.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Marketing & Advertising

Danes Get OTC Access To ED Treatment

 
• By 

Navamedic has launched Eroxon in Danish pharmacies giving men in the country OTC access to an ED treatment for the first time.

Alfasigma Seeking Slice Of EU’s Largest OTC Market With German Launch

 
• By 

Italy's Alfasigma has expanded its operation in Germany with the creation of a new Consumer Healthcare unit. Led by Rüdiger Hoppe, the business is rolling out OTC medical devices and dietary supplements in the gastrointestinal category.

Maxwellia Launches UK TV Campaign For Evana Showing Reality Of Menstruation

 
• By 

Maxwellia's “bold, honest, and completely unfiltered” campaign for Evana menstrual health brand tells the story of a woman dealing with the realities of a heavy period, showing “real blood, real leaks.”

Haleon Launches ‘Prescription Strength’ Hayfever Remedy In The UK

 
• By 

Pirilieve Hayfever Relief Tablets contain 120mg fexofenadine hydrochloride, which the firm notes is an active ingredient that was “previously only available behind pharmacy counters.”

More from Geography

Supplementation Unlikely To Help With Hereditary Hair Loss, Says German Agency

 
• By 

Germany’s Federal Institute for Risk Assessment says that there is "no evidence that people with androgenetic alopecia have special dietary needs or a special nutrient requirement.”

US Tariffs Pose ‘Existential Threat’ To EU Medical Devices Industry

 
• By 

AESGP, MedTech Europe and other associations representing medtech companies including manufacturers of self-care devices call for such products to be included in European Commission proposals for “zero-for-zero” trade in industrial goods between Europe and the US.

OTCs Are ‘Beacon Of Hope’ For Austrian Pharmacy

 
• By 

Just under half of Austrian pharmacists surveyed by Elpato Medien are “convinced that the OTC business will ensure the survival of their pharmacy.”